Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,320 signal articles · 250 in last 24h · 120,828 total before filter · latest 1h ago
250last 24h
1354last 7d
230● bullish (7d)
147● bearish (7d)
205publishers
AllMacro239Earnings481M&A104Regulatory19Product9Analyst20
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Chipotle Raises Full-Year Sales Outlook After Quarterly Earnings Beat
InvestorsHub21d agobullish
Chipotle Raises Full-Year Sales Outlook After Quarterly Earnings Beat

Chipotle Mexican Grill (NYSE:CMG) reported second-quarter results that topped Wall Street expectations and lifted its full-year comparable sales forecast, supported by restaurant expansion and continued execution of its long-term growth strategy. The stronger-than-expected performance sent the company’s shares up 5.

Arm Holdings Tops First-Quarter Forecasts, but Shares Extend Decline
InvestorsHub21d agobullish
Arm Holdings Tops First-Quarter Forecasts, but Shares Extend Decline

Arm Holdings (NASDAQ:ARM) reported first-quarter results that exceeded Wall Street expectations for both earnings and revenue, yet the chip designer’s shares continued to slide as investors remained cautious despite an upbeat outlook. The company posted earnings per share of $0.

Charles Schwab (SCHW) Could Be 15% Undervalued As Earnings Buybacks And Dividends Impress
Simply Wall St.21d agobullish
Charles Schwab (SCHW) Could Be 15% Undervalued As Earnings Buybacks And Dividends Impress

Charles Schwab (SCHW) just combined three shareholder friendly moves: a higher second quarter earnings print, fresh buyback progress, and confirmed common and preferred dividends, giving investors new information on both growth and income potential. See our latest analysis for Charles Schwab. At a share price of $104.47, Charles Schwab’s recent 30 day share price return of 15.37% and 90 day share price return of 14.00% sit alongside a 1 year total shareholder return of 7.33%, while the 3 year...

Teradyne (TER) Beats Q2 Expectations As AI Chip Demand Lifts Q3 Outlook
Simply Wall St.21d agobullish
Teradyne (TER) Beats Q2 Expectations As AI Chip Demand Lifts Q3 Outlook

Teradyne (NasdaqGS:TER) reported Q2 results that beat its own expectations, supported by demand for semiconductor test and robotics equipment. The company issued a strong Q3 revenue outlook, tied to increased testing needs for advanced AI chips in data centers and vehicles. Management highlighted rising investments in wafer fabrication and complex semiconductor testing as key drivers of current business trends. Teradyne sits at the heart of the chip supply chain, supplying test systems that...

How Investors May Respond To Qorvo (QRVO) Earnings Beat Amid Mixed Sales And Stronger Profit Margins
Simply Wall St.21d agobullish
How Investors May Respond To Qorvo (QRVO) Earnings Beat Amid Mixed Sales And Stronger Profit Margins

Qorvo, Inc. reported past first-quarter fiscal 2027 results to June 27, 2026, with sales of US$784.8 million versus US$818.78 million a year earlier, while net income rose to US$85.8 million from US$25.59 million, lifting basic earnings per share from continuing operations to US$0.97. Despite softer smartphone-related revenue, Qorvo’s High-Performance Analog business and cost controls boosted profitability, with earnings and sales exceeding analyst consensus for the quarter. Next, we’ll...

Rambus (RMBS) Is Down 19.8% After Record Q2 Results And AI Memory Wins - Has The Bull Case Changed?
Simply Wall St.21d agobullish
Rambus (RMBS) Is Down 19.8% After Record Q2 Results And AI Memory Wins - Has The Bull Case Changed?

Rambus Inc. recently reported second-quarter 2026 results showing revenue of US$207.39 million and net income of US$67.61 million, alongside the completion of a multi-year share repurchase program totaling 14,484,994 shares for US$466.93 million since its November 2020 authorization. The company reinforced its position in high-speed, AI-focused memory solutions by launching complete DDR5 9600 chipsets, securing a key next-generation HBM IP design win with a Tier-1 U.S. hyperscaler, and...

Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use
Simply Wall St.21d agobullish
Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use

Amgen (NasdaqGS:AMGN) received a positive opinion from the European Medicines Agency’s CHMP for an expanded Repatha indication in Europe. The recommendation covers use of Repatha to help reduce cardiovascular risk in high risk adults without a prior heart attack or stroke. The CHMP view is based on Phase 3 clinical data that showed a significant reduction in major adverse cardiovascular events. Amgen is a large biotech company with a focus on cardiometabolic, oncology and immunology...

Pfizer (PFE) Wins EU Approval For Updated COVID Vaccine Ahead Of 2026 Season
Simply Wall St.22d agobullish
Pfizer (PFE) Wins EU Approval For Updated COVID Vaccine Ahead Of 2026 Season

European Commission grants marketing authorization for Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine for the 2026-2027 season in the EU. Approval covers use in individuals aged 6 months and older across all EU member states. Authorization supports advance manufacturing and supply ahead of the upcoming respiratory disease season. Pfizer, listed as NYSE:PFE, now has European Commission authorization for its XFG-adapted COVID-19 vaccine for the 2026-2027 season. The decision confirms that...